Edwards Lifesciences oximetry central venous catheter continuously monitors central venous oxygen saturation (Scv02), an early indicator of compromised or inadequate oxygen delivery. By providing a more sensitive indicator of oxygen imbalance, Edwards oximetry central venous catheter identifies critical changes earlier than traditional vital signs and intermittent sampling— enabling you to recognize and prevent tissue hypoxia sooner.1

Edwards oximetry
central venous catheter

Continuous ScvO2 monitoring – The clarity in an early warning of oxygen imbalance.

Edwards oximetry central venous catheter – the first proven central venous catheter with continuous ScvO2 monitoring – reveals the true adequacy of tissue oxygenation for clarity in early assessment and intervention.1

Edwards oximetry central venous catheter

Edwards oximetry central venous catheter

Helps guide therapy and provide real-time insight into the efficacy of intervention.1

Continuous ScvO2 monitoring enables proactive management of tissue hypoxia:

  • Reveals the root cause of oxygen imbalance, enabling you to determine appropriate therapy early.1,7
  • Allows for immediate assessment of patient’s clinical response to therapy.1,2,6
  • Helps you stay ahead of tissue hypoxia and stages of sepsis.8–11

Convenient, accurate and easy to use

  • Offers continuous ScvO2 monitoring, pressure monitoring and infusions of solutions.
  • Provides accurate oxygenation status.

Edwards oximetry central venous catheter brochure

Model numbers

LumensLength (cm)
X3816ST 3 16
X3820ST 3 20
Clinical application

Early assessment with real-time ScvO2 monitoring enables proactive clinical decisions for your high-risk patients.1–5

Continuous ScvO2 monitoring is key to assessing the adequacy of the balance of oxygen delivery and consumption. The goal of continuous ScvO2 monitoring with the Edwards oximetry central venous catheter is to bring into balance the relationship between oxygen delivery and consumption to help improve the care of high-acuity patients.12

Demonstrated prognostic value of continuous ScvO2 monitoring can be seen in:

  • Post-op high-risk surgeries4,5,13-16
  • Trauma4
  • Sepsis19
  • Cardiac failure in congenital heart failure5
  • Recovery in cardiac arrest15,16

Continuous ScvO2 monitoring has multiple applications in intra- and post-op stages including:17,18

  • Risk for high blood loss, such as hepatic resections, trauma, vascular cases
  • High fluid shifts in gastrointestinal cases
  • Toleration of single-lung ventilation in thoracic procedures
  • Early indication of failure to tolerate extubation
Charts showing continuous ScvO2 monitoring hemodynamic trends
Balance of Oxygen Chart
Charts showing continuous ScvO2 monitoring hemodynamic trends
Balance of Oxygen Chart
Clinical evidence

Complete Hemodynamic Profiling with Pulmonary Artery Catheters in Cardiogenic Shock Is Associated with Lower In-Hospital Mortality

The objective of the study, directed by Garan et al., explored the potential benefit of obtaining a complete hemodynamic profile via pulmonary artery catheters (PAC) prior to administration of mechanical circulatory support (MCS) in cardiogenic shock (CS) patients. The study observed that CS patients with complete PAC data obtained prior to MCS had improved survival compared to those who did not.

Further, the study showed that an incomplete hemodynamic dataset was equivalent to having no PAC data with regard to in-hospital mortality. Additional benefits from complete PAC data acquisition include early identification of hemodynamic compromise requiring immediate MCS, in order to avoid potentially irreversible end-organ dysfunction as a result of treatment delays.

  • Lower mortality in patients with advanced stages of CS
  • Lowest in-hospital mortality across study sub-groups and SCAI stages
  • Early identification of hemodynamic compromise
  • An incomplete hemodynamic dataset is equivalent to having no PAC data
View study

“The complete PAC assessment group had the lowest in-hospital mortality compared to the other groups across all SCAI stages.”

Study by Garan et al.

Pulmonary Artery Catheter Use in Adult Patients Undergoing Cardiac Surgery: a retrospective, cohort study

In this retrospective study conducted by Shaw et al., the utility of pulmonary artery catheters (PAC) in complex cardiac surgeries, and their association with subsequent clinical outcomes including 30-day in-hospital mortality, major morbidity, and length of stay was examined.

The analysis comprised two cohorts totaling 6844 patients who underwent CABG, isolated valve surgery, aortic surgery and other complex procedures from January 1, 2011 to June 30, 2015. The study concluded PAC use did not contribute to in-hospital mortality and could be associated with a statistically significant decrease in length of hospital stay and a significant decrease in the cardiopulmonary morbidity composite.

  • Decreased LOS
  • Decreased pulmonary morbidity
  • No increased risk of in-hospital mortality
View study

“PAC use was associated with a statistically significant decrease in length of hospital stay and a significant decrease in the cardiopulmonary morbidity composite.”

Study by Shaw et al.
Related products

Contact us

The Edwards Advantage

We are committed to providing your institution, clinicians and staff with a high level of customer service and support to ensure seamless product implementation and ongoing use:

Contact a sales representative

Do you have feedback about our products? Click here

  1. Reinhart K, et al. Continuous central venous and pulmonary artery oxygen saturation monitoring in the critically ill. Intensive Care Med. 2004;30(8):1572-8.
  2. Rivers EP, et al. Central venous oxygen saturation monitoring in the critically ill patient. Curr Opin Crit Care. 2001;7(3):204-11.
  3. Ingelmo P, et al. Importance of monitoring in high risk surgical patients. Minerva Anestesiol. 2002;68(4):226-30.
  4. Scalea, TM, et al. Central venous oxygen saturation: a useful clinical tool in trauma patients. J Trauma 1990;30(12):1539-43.
  5. Ander, DS, et al. Undetected cardiogenic shock in patients with congestive heart failure presenting to the emergency department. Am J Cardiol 1998;82(7):888-91.
  6. Tweddell, JS, et al. Mixed venous oxygen saturation monitoring after stage 1 palliation for hypoplastic left heart syndrome. Ann Thorac Surg 2007;84:1301-1311
  7. Zaja J. Venous oximetry. Signa Vitae 2007;2(1):6-10.
  8. Spenceley, N., et al. Continuous central venous saturations during pericardial tamponade case report. Pediatr Crit Care Med 2007,Vol. 8,No. 3,p18.2.153.
  9. Krahn, G., et al. Early clinical evaluation of the Edwards PediaSat™ oximetry catheter in pediatric patients. Pediatr Crit Care Med 2007,Vol. 8,No. 3,p18.2.152.
  10. Spenceley, N., et al. Continuous central venous saturation monitoring in pediatrics: a case report. Pediatr Crit Care Med 2008, Vol. 9, No. 2, p e13-e16
  11. Lemson et al. Advanced hemodynamic monitoring in critically ill patients. Pediatrics. 2011
  12. Nelson, L. Continuous venous oximetry in surgical patients. Ann Surg. 1986;203/3:329-333.
  13. Pearse, R, et al. Changes in central venous saturation after major surgery, and association with outcome. Crit Care 2005;9(6):R694-91.
  14. Rady, MY, et al. Resuscitation of the critically ill in the ED: responses of blood pressure, heart rate, shock index, central venous oxygen saturation, and lactate. Am J Emerg Med 1996;14(2):218-25.
  15. Rivers, EP, et al. The clinical implications of continuous central venous oxygen saturation during human CPR. Ann Emerg Med 1992;21(9):1094-101.
  16. Nakazawa, K, et al. Usefulness of central venous oxygen saturation monitoring during cardiopulmonary resuscitation. A comparative case study with end-tidal carbon dioxide monitoring. Intensive Care Med 1994;20(6):450-1.
  17. Noguiera P, et al. Central Venous Saturation: A Prognostic Tool in Cardiac Surgery Patients. J Intensive Care Med. 2010;25(2):111-116.
  18. Vallet B, et al. Venous oxygen saturation as a physiologic transfusion trigger. Crit Care. 2010;14:213.
  19. Rivers, et al. Early interventions in severe sepsis and septic shock. 2012. Minerva Media. 712-724.

For professional use

For professional use

For a listing of indications, contraindications, precautions, warnings, and potential adverse events, please refer to the Instructions for Use (consult eifu.edwards.com where applicable).

Edwards Lifesciences devices placed on the European market meeting the essential requirements referred to in Article 3 of the Medical Device Directive 93/42/EEC bear the CE marking of conformity.

Please update your browserClose this window

Please update to a current version of your preferred browser, this site will perform effectively on the following:

Unable to update your browser?

If you are on a computer, that is maintained by an admin and you cannot install a new browser, ask your admin about it. If you can't change your browser because of compatibility issues, think about installing a second browser for browsing and keep this old one for compatibility